We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $481M
1-Year Est. Return 35.73%
This Fund
S&P 500
This Quarter Est. Return
-8.42%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$396M
AUM Growth
-$18.2M
Cap. Flow
+$23.9M
Cap. Flow %
6.04%
Top 10 Hldgs %
72.08%
Holding
49
New
3
Increased
19
Reduced
15
Closed
9

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.71M
2
FIVE icon
Five Below
FIVE
+$2.84M
3
AZN icon
AstraZeneca
AZN
+$799K
4
GILD icon
Gilead Sciences
GILD
+$771K
5
URGN icon
UroGen Pharma
URGN
+$370K

Sector Composition

Rank Sector Weight
1 Technology 42.31%
2 Consumer Discretionary 23.83%
3 Healthcare 17.99%
4 Communication Services 11.66%
5 Financials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
26
Costco
COST
$419B
$1.37M 0.35%
1,451
-31
-2% -$30.2K
ABBV icon
27
AbbVie
ABBV
$451B
$705K 0.18%
3,364
-933
-22% -$181K
JPM icon
28
JPMorgan Chase
JPM
$951B
$631K 0.16%
2,574
-180
-7% -$45.9K
JNJ icon
29
Johnson & Johnson
JNJ
$646B
$613K 0.15%
3,698
-21
-0.6% -$3.29K
ABT icon
30
Abbott
ABT
$195B
$542K 0.14%
4,085
-1,553
-28% -$198K
DE icon
31
Deere & Co
DE
$170B
$466K 0.12%
992
-20
-2% -$9.36K
MRK icon
32
Merck
MRK
$366B
$443K 0.11%
4,932
-50
-1% -$4.67K
V icon
33
Visa
V
$712B
$354K 0.09%
1,009
CAT icon
34
Caterpillar
CAT
$368B
$351K 0.09%
1,064
-20
-2% -$7.12K
GILD icon
35
Gilead Sciences
GILD
$181B
$323K 0.08%
2,887
-7,476
-72% -$771K
NUE icon
36
Nucor
NUE
$56.8B
$292K 0.07%
2,425
ORCL icon
37
Oracle
ORCL
$435B
$282K 0.07%
2,014
+65
+3% +$10.6K
DUK icon
38
Duke Energy
DUK
$93.8B
$225K 0.06%
+1,848
New +$211K
PAYX icon
39
Paychex
PAYX
$45.2B
$224K 0.06%
1,455
AEP icon
40
American Electric Power
AEP
$66.6B
$224K 0.06%
+2,050
New +$208K
AZN icon
41
AstraZeneca
AZN
$252B
-6,101
Closed -$799K
BCRX icon
42
BioCryst Pharmaceuticals
BCRX
$2.51B
-23,710
Closed -$178K
EOLS icon
43
Evolus
EOLS
$587M
-25,070
Closed -$277K
FIVE icon
44
Five Below
FIVE
$13.4B
-27,048
Closed -$2.84M
PLSE icon
45
Pulse Biosciences
PLSE
$3.39B
-11,590
Closed -$202K
SMMT icon
46
Summit Therapeutics
SMMT
$11B
-11,496
Closed -$205K
TROW icon
47
T. Rowe Price
TROW
$23.7B
-1,770
Closed -$200K
URGN icon
48
UroGen Pharma
URGN
$2.13B
-34,701
Closed -$370K
CMRX
49
DELISTED
Chimerix, Inc.
CMRX
-10,609
Closed -$36.9K

Similar funds

Bender Robert & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Bender Robert & Associates held 49 positions worth $396M, down 4.4% from $414M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bender Robert & Associates deployed $23.9M of net new capital in Q1 2025, opening 3 new positions and adding to 19 existing holdings. Its largest new stake was Chipotle Mexican Grill: 144,933 shares worth $7.28M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 44% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was NVIDIA, an estimated $6.71M trimmed.

  • Bender Robert & Associates's largest Q1 2025 buy was Chipotle Mexican Grill: 144,933 shares worth $7.28M.
  • Bender Robert & Associates added most to Apple in Q1 2025, an estimated $10.1M increase.
  • Bender Robert & Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $6.71M.
  • Bender Robert & Associates fully exited Five Below in Q1 2025, selling an estimated $2.84M.
  • Bender Robert & Associates's ten largest holdings make up 72% of its $396M portfolio in Q1 2025.
  • Bender Robert & Associates opened 3 new positions and closed 9 in Q1 2025.
  • Bender Robert & Associates's portfolio value fell 4.4% quarter-over-quarter to $396M.

Based on Bender Robert & Associates's 13F filing for Q1 2025, filed 18 Apr 2025.